Skip to main content

Peer Review reports

From: Evaluation of injection-site-related adverse events with galcanezumab: a post hoc analysis of phase 3 studies in participants with migraine

Original Submission
15 Feb 2020 Submitted Original manuscript
24 Feb 2020 Reviewed Reviewer Report - Maria Pia Prudenzano
9 Apr 2020 Reviewed Reviewer Report - Giuseppe Murdaca
11 Apr 2020 Reviewed Reviewer Report - Noah Rosen
27 Apr 2020 Author responded Author comments - Virginia L. Stauffer
4 May 2020 Author responded Author comments - Virginia L. Stauffer
Resubmission - Version 2
27 Apr 2020 Submitted Manuscript version 2
7 May 2020 Author responded Author comments - Virginia L. Stauffer
Resubmission - Version 3
7 May 2020 Submitted Manuscript version 3
Publishing
10 May 2020 Editorially accepted
19 May 2020 Article published 10.1186/s12883-020-01775-4

You can find further information about peer review here.

Back to article page